INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

82,042 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
RJ
Running Michael J.Regional President - AMER
PLXSPLEXUS CORP
Grant or award
A—
1,550 sh
Feb 9, 2026Feb 11, 2026
Page 1582 of 2052
← PrevNext →
traded Feb 9, 2026
+2d
SEC Form 4

Evidence

5
SM
Stasiowska Ewa MariaChief Risk Officer
LOBLive Oak Bancshares, Inc.
Grant or award
A—
8,383 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

5
HJ
Hill Stephen J.Chief Operating Officer
LYELLyell Immunopharma, Inc.
Grant or award
A—
65.0K sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC Form 4

Evidence

5
YH
Yang HongyongVP and GM Fuel Syst. Asia Pac
PHINPHINIA INC.
Grant or award
A—
1,197 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

5
SC
Spencer CourtneyChief Experience Officer
LOBLive Oak Bancshares, Inc.
Tax withholding
F$29K
709 sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC Form 4

Evidence

5
LE
Lentell EricChief Legal & Strategy Officer
ACHRArcher Aviation Inc.
Grant or award
A—
185.2K sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

5
LK
Lee Gary K.Chief Scientific Officer
LYELLyell Immunopharma, Inc.
Grant or award
A—
50.0K sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC Form 4

Evidence

5
LA
Landry Stephen AlanSVP, Chief Operations Officer
THSTreeHouse Foods, Inc.
Disposition to issuer
D—
19.6K sh
Feb 11, 2026Feb 11, 2026
traded Feb 11, 2026
+0dSEC Form 4

Evidence

5
GP
Gupta PriyaInterim CFO
ACHRArcher Aviation Inc.
Grant or award
A—
123.5K sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

5
MH
Mitchell Max HDirector, Chairman, President and CEO
CRCrane Co
Grant or award
A—
8,938 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

5
MH
Mitchell Max HDirector, Chairman, President and CEO
CRCrane Co
Grant or award
A—
9,219 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

5
LA
Landry Stephen AlanSVP, Chief Operations Officer
THSTreeHouse Foods, Inc.
Disposition to issuer
D—
21.7K sh
Feb 11, 2026Feb 11, 2026
traded Feb 11, 2026
+0dSEC Form 4

Evidence

5
LA
Landry Stephen AlanSVP, Chief Operations Officer
THSTreeHouse Foods, Inc.
Option exercise
M—
19.6K sh
Feb 11, 2026Feb 11, 2026
traded Feb 11, 2026
+0dSEC Form 4

Evidence

5
LA
Landry Stephen AlanSVP, Chief Operations Officer
THSTreeHouse Foods, Inc.
Grant or award
A—
21.7K sh
Feb 11, 2026Feb 11, 2026
traded Feb 11, 2026
+0dSEC Form 4

Evidence

5
SC
Spencer CourtneyChief Experience Officer
LOBLive Oak Bancshares, Inc.
Grant or award
A—
6,586 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

4
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$160K
205 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

4
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$113K
144 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

4
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$66K
2,171 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

4
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$59K
75 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

3
BL
Bayview Legacy, LLC10% Owner
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
2,756 sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$16K
20 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$175K
2,500 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
DK
DeHoff KateSee Remarks
JOBYJoby Aviation, Inc.
Open-market sale · 10b5-1 plan
SELL$11K
1,076 sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$20K
26 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$42K
53 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$29K
37 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$785
1 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Option exercise · 10b5-1 plan
M$113K
2,520 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
DK
DeHoff KateSee Remarks
JOBYJoby Aviation, Inc.
Option exercise · 10b5-1 plan
M—
2,958 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
RM
Ragosa MarkCHIEF FINANCIAL OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M$42K
2,471 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
DK
DeHoff KateSee Remarks
JOBYJoby Aviation, Inc.
Option exercise · 10b5-1 plan
M—
2,958 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
567 sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC Form 4

Evidence

0
RM
Ragosa MarkCHIEF FINANCIAL OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M—
8,374 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
2,171 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M—
1,000 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
AE
Apostolides James EChief Infra & Performance Ofcr
BKRBaker Hughes Co
Option exercise · 10b5-1 plan
M—
11.0K sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC Form 4

Evidence

0
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$35K
2,171 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
RM
Ragosa MarkCHIEF FINANCIAL OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M—
2,471 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Option exercise · 10b5-1 plan
M—
2,520 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

59
SA
Sacks Anelise AngelinoDirector
RALRalliant Corp
Open-market purchase
BUY$83K
2,000 sh
Feb 9, 2026Feb 10, 2026
traded Feb 9, 2026
+1dSEC Form 4

Evidence